A systematic review & meta-analysis comparing outcomes of endoscopic treatment of primary vesico ureteric reflux in children with polyacrylate poly alcohol copolymer versus dextranomer hyaluranic acid

Background & aims: There are conflicting reports on the efficacy of bulking agents for vesico ureteric reflux (VUR). In this meta-analysis we have compared the outcomes of endoscopic treatment with poly-acrylate polyalcohol copolymer (PPC) and dextranomer hyaluronic acid (DxHA).Methods: A systematic review of publications between 2010 and 2020 was conducted covering databases like PUBMED, MEDLINE etc. for (endoscopic treatment) AND (VUR) AND (PPC OR DxHA) AND (recurrence OR complications). PRISMA guidelines were followed and only comparative studies were included. Out-comes were early success defined as absence of VUR in voiding cystourethrogram at 3-months followup, urinary tract infections (UTI) and occurrence of vesico-ureteric-junction obstruction (VUJO). Risk of bias was analysed with Robvis tool and odds-ratios were compared with Revman-3.0.Results: Among nine studies (heterogeneity; I 2 69-79%) all cleared the risk of bias assessment. There was no significant difference in high grade VUR ( p = 0.94) between PPC (40%) and DxHA (43%). Success rate after single injection was significantly higher ( p = 0.0 0 01) at 86% (477/555) for PPC vs 69% (474/685) for DxHA. UTI rate between PPC (12%) and DxHA (14.6%) was not statistically significant ( p = 0.54). VUJO rate between PPC (3.9%) and DxHA (0.8%) was also not significantly different ( p = 0.47). Significantly lesser volume ( p = 0.02) was used for PPC (0.7 ml) compared to DxHA (0.9 ml).Conclusion: Reflux resolution was significantly higher with PPC than DxHA. Postinjection UTI/VUJO inci-dence was not significantly different between them. Limitation of this meta-analysis was heterogeneity & small number of articles. Further studies should focus on long-term outcomes and cost-effectiveness.(c) 2022 Elsevier Inc. All rights reserved.